Basics Royalty Pharma plc IPO Date: June 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $16.97B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 1.19% Avg Daily Range (30 D): $0.45 | 1.19% Avg Daily Range (90 D): $0.40 | 1.09% Institutional Daily Volume Avg Daily Volume: 2.09M Avg Daily Volume (30 D): 3.16M Avg Daily Volume (90 D): 2.98M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 8,811 Avg Inst. Trade: $4.68M Avg Inst. Trade (30 D): $6.63M Avg Inst. Trade (90 D): $6.48M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 6 Market Closing Trades Avg Closing Trade: $13.8M Avg Closing Trade (30 D): $22.88M Avg Closing Trade (90 D): $29.99M Avg Closing Volume: 388.72K     News Nov 5, 2025 @ 9:00 PM Cytokinetics Reports Third Quarter 2025 Financial ... Source: Cytokinetics, Incorporated Sep 3, 2025 @ 12:30 AM Royalty Pharma Announces Pricing of $2.0 Billion o... Source: Royalty Pharma Aug 25, 2025 @ 10:10 AM Royalty Pharma to Acquire Royalty Interest in Amge... Source: Globe Newswire Jul 18, 2025 @ 12:15 PM Royalty Pharma Declares Third Quarter 2025 Dividen... Source: Globe Newswire May 16, 2025 @ 8:30 PM Royalty Pharma Completes the Acquisition of Its Ex... Source: Globe Newswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $.67 $.07 Diluted EPS $.67 $.07 Revenue $ $ 609.29M $ 578.67M Gross Profit $ $ $ Net Income / Loss $ $ 444.21M $ 90.64M Operating Income / Loss $ $ 427.16M $ 209.8M Cost of Revenue $ $ $ Net Cash Flow $ $ 307.04M $ -455.81M PE Ratio     Splits Oct 15, 2010:   1:4